EUVIMEDEUVIMED entdecken
Open Access

Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations

James L Ross, Montserrat Puigdelloses-Vallcorba, Gonzalo Piñero, Nishant Soni, Wes Thomason, John DeSisto, Angelo Angione, Nadejda M Tsankova, Maria G Castro, Matthew Schniederjan, Nitin R Wadhwani, G Praveen Raju und 5 weitere

Immunity · 2024-11 · 57 (11) · 2669-2687.e6

DOI: 10.1016/j.immuni.2024.09.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2024-11. Verfasst von James L Ross und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Glioma, Histones, Microglia, Mutation. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, Cancer Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric high-grade gliomas (pHGGs), including hemispheric pHGGs and diffuse midline gliomas (DMGs), harbor mutually exclusive tumor location-specific histone mutations. Using immunocompetent de novo mouse models of pHGGs, we demonstrated that myeloid cells were the predominant infiltrating non-neoplastic cell population. Single-cell RNA sequencing (scRNA-seq), flow cytometry, and immunohistochemistry illustrated the presence of heterogeneous myeloid cell populations shaped by histone mutations and tumor location. Disease-associated myeloid (DAM) cell phenotypes demonstrating immune permissive characteristics were identified in murine and human pHGG samples. H3.3K27M DMGs, the most aggressive DMG, demonstrated enrichment of DAMs. Genetic ablation of chemokines Ccl8 and Ccl12 resulted in a reduction of DAMs and an increase in lymphocyte infiltration, leading to increased survival of tumor-bearing mice. Pharmacologic inhibition of chemokine receptors CCR1 and CCR5 resulted in extended survival and decreased myeloid cell infiltration. This work establishes the tumor-promoting role of myeloid cells in DMG and the potential therapeutic opportunities for targeting them.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaHistonesMicrogliaMutationBrain NeoplasmsMacrophagesDisease ProgressionAnimalsMiceHumansChildReceptors, CCR1Receptors, CCR5Myeloid CellsDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

CCR1CCR5TAMdiffuse midline gliomadisease-associated macrophagehigh-grade gliomamacrophagemicrogliamonocytepediatric glioma

Substanzen

HistonesReceptors, CCR1Receptors, CCR5Ccr1 protein, mouse

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Neurosurgery, Mount Sinai Icahn School of Medicine, New York, NY, USA.
  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Morgan Adams Foundation Pediatric Brain Tumor Research Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Cell Biology, Stem Cells and Development Graduate Program, Aurora, CO, USA; Center for Can…
  • Department of Pathology and Molecular and Cell-Based Medicine, Mount Sinai Icahn School of Medicine, New York, NY 10029, USA.
  • Departments of Neurosurgery and Cell & Developmental Biology, The University of Michigan School of Medicine, Ann Arbor, MI, USA.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • Cancer Research Institute
  • National Institutes of Health
  • Cure Starts Now Foundation

Zitieren

APA

Ross, J. L., Puigdelloses-Vallcorba, M., Piñero, G., Soni, N., Thomason, W., DeSisto, J., Angione, A., Tsankova, N. M., Castro, M. G., Schniederjan, M., Wadhwani, N. R., Raju, G. P., Morgenstern, P., Becher, O. J., Green, A. L., Tsankov, A. M., & Hambardzumyan, D. (2024). Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations. Immunity, 57(11), 2669-2687.e6. https://doi.org/10.1016/j.immuni.2024.09.007

Vancouver

Ross JL, Puigdelloses-Vallcorba M, Piñero G, Soni N, Thomason W, DeSisto J, et al. Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations. Immunity. 2024;57(11):2669-2687.e6. doi:10.1016/j.immuni.2024.09.007

BibTeX
@article{Ross2024,
  author = {Ross, James L and Puigdelloses-Vallcorba, Montserrat and Piñero, Gonzalo and Soni, Nishant and Thomason, Wes and DeSisto, John and Angione, Angelo and Tsankova, Nadejda M and Castro, Maria G and Schniederjan, Matthew and Wadhwani, Nitin R and Raju, G Praveen and Morgenstern, Peter and Becher, Oren J and Green, Adam L and Tsankov, Alexander M and Hambardzumyan, Dolores},
  title = {Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations},
  journal = {Immunity},
  year = {2024},
  volume = {57},
  number = {11},
  pages = {2669--2687.e6},
  doi = {10.1016/j.immuni.2024.09.007}
}
Kostenlos starten →